Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry E Rosenbloom

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Expert Review of Endocrinology & Metabolism|February 13, 2019
Bone disease in patients with Gaucher diseaseBarry E Rosenbloom, Neal J Weinreb
Critical Reviews in Oncogenesis|March 21, 2013
Gaucher disease: a comprehensive reviewBarry E Rosenbloom, Neal J Weinreb
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2002
Gaucher disease with nephrotic syndrome: response to enzyme replacement therapyDomenico Santoro, Barry E Rosenbloom, Arthur H Cohen
American Journal of Hematology|June 23, 2015
Gaucher disease and comorbidities: B-cell malignancy and parkinsonismTimothy M Cox, Barry E Rosenbloom, Roger A Barker
Critical Reviews in Oncogenesis|March 21, 2013
Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolismPramod K Mistry, Tamar Taddei, Stephan vom Dahl, et al.
Blood|February 19, 2005
Gaucher disease and cancer incidence: a study from the Gaucher RegistryBarry E Rosenbloom, Neal J Weinreb, Ari Zimran, et al.
Orphanet Journal of Rare Diseases|May 22, 2015
Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3)Neal J Weinreb, David N Finegold, Eleanor Feingold, et al.
Molecular Genetics and Metabolism|March 20, 2025
Challenges in Gaucher disease: Perspectives from an expert panelGregory A Grabowski, Priya S Kishnani, Roy N Alcalay, et al.
American Journal of Hematology|September 2, 2022
Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher RegistryBarry E Rosenbloom, Maria Domenica Cappellini, Neal J Weinreb, et al.
The American Journal of Medicine|July 23, 2002
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher RegistryNeal J Weinreb, Joel Charrow, Hans C Andersson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Review of Endocrinology & Metabolism|February 13, 2019
Bone disease in patients with Gaucher diseaseBarry E Rosenbloom, Neal J Weinreb
Critical Reviews in Oncogenesis|March 21, 2013
Gaucher disease: a comprehensive reviewBarry E Rosenbloom, Neal J Weinreb
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2002
Gaucher disease with nephrotic syndrome: response to enzyme replacement therapyDomenico Santoro, Barry E Rosenbloom, Arthur H Cohen
American Journal of Hematology|June 23, 2015
Gaucher disease and comorbidities: B-cell malignancy and parkinsonismTimothy M Cox, Barry E Rosenbloom, Roger A Barker
Critical Reviews in Oncogenesis|March 21, 2013
Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolismPramod K Mistry, Tamar Taddei, Stephan vom Dahl, et al.
Blood|February 19, 2005
Gaucher disease and cancer incidence: a study from the Gaucher RegistryBarry E Rosenbloom, Neal J Weinreb, Ari Zimran, et al.
Orphanet Journal of Rare Diseases|May 22, 2015
Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3)Neal J Weinreb, David N Finegold, Eleanor Feingold, et al.
Molecular Genetics and Metabolism|March 20, 2025
Challenges in Gaucher disease: Perspectives from an expert panelGregory A Grabowski, Priya S Kishnani, Roy N Alcalay, et al.
American Journal of Hematology|September 2, 2022
Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher RegistryBarry E Rosenbloom, Maria Domenica Cappellini, Neal J Weinreb, et al.
The American Journal of Medicine|July 23, 2002
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher RegistryNeal J Weinreb, Joel Charrow, Hans C Andersson, et al.
Pageof 2